XML 73 R61.htm IDEA: XBRL DOCUMENT v3.25.1
Borrowings - SPV II Credit Facility (Details) - USD ($)
$ in Thousands
12 Months Ended 36 Months Ended
Dec. 20, 2026
Dec. 31, 2025
Dec. 20, 2025
Mar. 31, 2025
Dec. 31, 2024
Jun. 18, 2024
Dec. 20, 2022
Borrowings              
Fair value       $ 4,520,627 [1],[2] $ 4,008,973 [3],[4]    
SPV II Credit Facility              
Borrowings              
Maximum borrowing capacity           $ 245,447 $ 100,000
Interest rate, floor       0.50%      
Weighted average interest rate       6.70% 6.90%    
Percentage of principal proceeds to be reinvested             25.00%
SPV II Credit Facility | Forecast              
Borrowings              
Interest rate, basis spread 3.40% 2.40%          
Percentage of principal proceeds to be prepaid 100.00%   75.00%        
SPV II Credit Facility | Asset pledged as collateral              
Borrowings              
Fair value       $ 290,939 $ 307,517    
[1] All of the Company’s investments are issued by eligible portfolio companies, as defined in the Investment Company Act of 1940, as amended, (the “1940 Act”), unless otherwise noted. All of the Company’s investments are issued by U.S. portfolio companies unless otherwise noted.
[2] Except as otherwise noted, because there is no readily available market value for these investments, the fair value of each of these investments is determined in good faith using significant unobservable inputs by the Valuation Designee. (See Note 4 in the accompanying notes to the consolidated financial statements).
[3] All of the Company’s investments are issued by eligible portfolio companies, as defined in the Investment Company Act of 1940, as amended, (the “1940 Act”), unless otherwise noted. All of the Company’s investments are issued by U.S. portfolio companies unless otherwise noted.
[4] Except as otherwise noted, because there is no readily available market value for these investments, the fair value of each of these investments is determined in good faith using significant unobservable inputs by the Valuation Designee. (See Note 4 in the accompanying notes to the consolidated financial statements).